Concepedia

Juha‐Matti Savola

JS

63

Publications

3.7K

Citations

34

H-Index

1968

Active since

Affiliations

Orion Corporation (Finland)(Current)

Teva Pharmaceuticals (United States)

Teva Pharmaceuticals (Switzerland)

University of Turku

Teva Pharmaceuticals (Israel)

Juha‐Matti Savola is an author at Orion Corporation (Finland) specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

MedicinePharmacologyMolecular PharmacologyPhysiologyPharmacotherapyNeuropharmacologySignal TransductionAlpha-adrenergic PharmacologyBiochemistryDrug Discovery

Publications per year

1968–2024

63

Publications

63

Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist

Raimo Virtanen, Juha‐Matti Savola, Veijo Saano et al. · European Journal of Pharmacology · 1988 · 691 citations

Molecular Pharmacology, Functional Selectivity, Medicine +10

Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.

R Virtanen, Juha‐Matti Savola, Veijo Saano · PubMed · 1989 · 179 citations

Specific Antagonist, Pharmacotherapy, Medetomidine-induced Sedation +19

Fipamezole (JP‐1730) is a potent α<sub>2</sub> adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease

Juha‐Matti Savola, Michael P. Hill, Mia Engström et al. · Movement Disorders · 2003 · 155 citations

Psychotropic Medication, Pharmacotherapy, Levodopa‐induced Dyskinesia +16

EVIDENCE FOR MEDETOMIDINE AS A SELECTIVE AND POTENT AGONIST α<sub>2</sub>‐ADRENORECEPTORS

Juha‐Matti Savola, Heikki Ruskoaho, Juhani Puurunen et al. · Journal of Autonomic Pharmacology · 1986 · 146 citations

Central α2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine

Juha‐Matti Savola, Raimo Virtanen · European Journal of Pharmacology · 1991 · 137 citations

Molecular Pharmacology, Adrenal Gland, Medicine +5

Rows per page

1–5 of 63